| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging, Cine | 40 | 2024 | 975 | 5.550 |
Why?
|
| Heart Ventricles | 45 | 2024 | 3772 | 3.280 |
Why?
|
| Tetralogy of Fallot | 26 | 2023 | 634 | 3.070 |
Why?
|
| Heart Defects, Congenital | 44 | 2024 | 4656 | 2.430 |
Why?
|
| Ventricular Function, Left | 27 | 2024 | 3706 | 2.130 |
Why?
|
| Pulmonary Valve Insufficiency | 10 | 2021 | 153 | 2.130 |
Why?
|
| Magnetic Resonance Angiography | 15 | 2021 | 1419 | 2.040 |
Why?
|
| Pulmonary Valve | 13 | 2021 | 428 | 2.010 |
Why?
|
| Fontan Procedure | 24 | 2023 | 786 | 1.840 |
Why?
|
| Ventricular Function, Right | 15 | 2018 | 595 | 1.770 |
Why?
|
| Myocardial Contraction | 9 | 2019 | 1502 | 1.750 |
Why?
|
| Ventricular Dysfunction, Left | 13 | 2022 | 2057 | 1.620 |
Why?
|
| Heart | 18 | 2024 | 4359 | 1.310 |
Why?
|
| Pulmonary Artery | 18 | 2018 | 1920 | 1.300 |
Why?
|
| Magnetic Resonance Imaging | 68 | 2024 | 35800 | 1.170 |
Why?
|
| Imaging, Three-Dimensional | 11 | 2024 | 4012 | 1.160 |
Why?
|
| Ventricular Dysfunction, Right | 12 | 2024 | 604 | 1.140 |
Why?
|
| Stroke Volume | 34 | 2024 | 5142 | 1.080 |
Why?
|
| Myocardium | 16 | 2022 | 4634 | 1.070 |
Why?
|
| Cardiac Surgical Procedures | 20 | 2024 | 3541 | 1.020 |
Why?
|
| Transposition of Great Vessels | 8 | 2018 | 588 | 1.000 |
Why?
|
| Ventricular Septum | 2 | 2023 | 75 | 0.960 |
Why?
|
| Pulmonary Atresia | 7 | 2011 | 160 | 0.960 |
Why?
|
| Hypoplastic Left Heart Syndrome | 6 | 2024 | 590 | 0.940 |
Why?
|
| Predictive Value of Tests | 31 | 2024 | 15012 | 0.910 |
Why?
|
| Ventricular Remodeling | 10 | 2018 | 1224 | 0.910 |
Why?
|
| Cardiac Imaging Techniques | 5 | 2024 | 272 | 0.860 |
Why?
|
| Collateral Circulation | 4 | 2013 | 276 | 0.850 |
Why?
|
| Aortic Valve Stenosis | 7 | 2015 | 2039 | 0.840 |
Why?
|
| Echocardiography | 23 | 2024 | 4910 | 0.790 |
Why?
|
| Heart Valve Prosthesis Implantation | 9 | 2020 | 1573 | 0.780 |
Why?
|
| Echocardiography, Doppler | 10 | 2018 | 899 | 0.760 |
Why?
|
| Cardiac-Gated Imaging Techniques | 3 | 2021 | 139 | 0.750 |
Why?
|
| Ventricular Dysfunction | 3 | 2014 | 142 | 0.740 |
Why?
|
| Coronary Circulation | 6 | 2020 | 1558 | 0.720 |
Why?
|
| Respiration | 5 | 2024 | 1644 | 0.700 |
Why?
|
| Child | 99 | 2024 | 78520 | 0.670 |
Why?
|
| Respiratory-Gated Imaging Techniques | 2 | 2024 | 75 | 0.670 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 2372 | 0.670 |
Why?
|
| Motion | 4 | 2017 | 781 | 0.660 |
Why?
|
| Coronary Vessel Anomalies | 5 | 2016 | 313 | 0.620 |
Why?
|
| Tricuspid Valve | 3 | 2018 | 402 | 0.620 |
Why?
|
| Adolescent | 93 | 2024 | 86324 | 0.600 |
Why?
|
| Pulmonary Circulation | 5 | 2018 | 742 | 0.600 |
Why?
|
| Image Interpretation, Computer-Assisted | 9 | 2021 | 3307 | 0.590 |
Why?
|
| Child, Preschool | 67 | 2024 | 41409 | 0.590 |
Why?
|
| Ebstein Anomaly | 1 | 2018 | 101 | 0.580 |
Why?
|
| Recovery of Function | 9 | 2020 | 2925 | 0.580 |
Why?
|
| Image Processing, Computer-Assisted | 15 | 2022 | 8906 | 0.570 |
Why?
|
| Cardiovascular System | 3 | 2022 | 830 | 0.560 |
Why?
|
| Coronary Vessels | 6 | 2016 | 3073 | 0.560 |
Why?
|
| Sodium Channels | 11 | 2010 | 342 | 0.550 |
Why?
|
| Infant | 56 | 2024 | 35465 | 0.550 |
Why?
|
| Exercise Tolerance | 8 | 2019 | 789 | 0.540 |
Why?
|
| Iron Overload | 3 | 2021 | 239 | 0.540 |
Why?
|
| Diaphragm | 2 | 2017 | 350 | 0.530 |
Why?
|
| Young Adult | 54 | 2024 | 57215 | 0.520 |
Why?
|
| Ventricular Pressure | 2 | 2015 | 201 | 0.510 |
Why?
|
| Aortic Coarctation | 4 | 2015 | 282 | 0.500 |
Why?
|
| Diastole | 8 | 2022 | 775 | 0.500 |
Why?
|
| Endocardial Cushion Defects | 1 | 2014 | 43 | 0.490 |
Why?
|
| Retrospective Studies | 64 | 2024 | 78360 | 0.490 |
Why?
|
| Contrast Media | 14 | 2020 | 5255 | 0.480 |
Why?
|
| Reproducibility of Results | 27 | 2024 | 19825 | 0.480 |
Why?
|
| Leukemia | 1 | 2022 | 1500 | 0.470 |
Why?
|
| Humans | 187 | 2024 | 746839 | 0.450 |
Why?
|
| Artifacts | 3 | 2024 | 1873 | 0.450 |
Why?
|
| Heart Diseases | 6 | 2024 | 2765 | 0.450 |
Why?
|
| Iron | 4 | 2021 | 1736 | 0.450 |
Why?
|
| Health Resources | 2 | 2017 | 906 | 0.430 |
Why?
|
| Myocarditis | 2 | 2021 | 763 | 0.420 |
Why?
|
| Pulmonary Valve Stenosis | 3 | 2018 | 176 | 0.420 |
Why?
|
| Adult | 83 | 2024 | 215288 | 0.420 |
Why?
|
| Aorta | 9 | 2016 | 2026 | 0.410 |
Why?
|
| Male | 114 | 2024 | 351538 | 0.410 |
Why?
|
| Iron Chelating Agents | 2 | 2014 | 137 | 0.400 |
Why?
|
| Catheterization | 4 | 2010 | 1426 | 0.400 |
Why?
|
| Angiography | 4 | 2020 | 1597 | 0.390 |
Why?
|
| Heart Neoplasms | 4 | 2011 | 359 | 0.390 |
Why?
|
| Hemosiderosis | 1 | 2012 | 67 | 0.390 |
Why?
|
| Observer Variation | 12 | 2018 | 2578 | 0.390 |
Why?
|
| Thalassemia | 2 | 2008 | 268 | 0.370 |
Why?
|
| Postoperative Care | 1 | 2017 | 1467 | 0.370 |
Why?
|
| Female | 109 | 2024 | 382565 | 0.370 |
Why?
|
| Blood Flow Velocity | 7 | 2012 | 1367 | 0.360 |
Why?
|
| Aorta, Thoracic | 6 | 2015 | 1050 | 0.360 |
Why?
|
| Exercise | 3 | 2022 | 5689 | 0.350 |
Why?
|
| Gadolinium DTPA | 6 | 2016 | 824 | 0.350 |
Why?
|
| Health Promotion | 1 | 2022 | 2191 | 0.350 |
Why?
|
| Heart Bypass, Right | 1 | 2009 | 75 | 0.330 |
Why?
|
| Phantoms, Imaging | 7 | 2022 | 2469 | 0.330 |
Why?
|
| Algorithms | 14 | 2024 | 13814 | 0.320 |
Why?
|
| Dobutamine | 1 | 2009 | 116 | 0.320 |
Why?
|
| Time Factors | 26 | 2024 | 39639 | 0.310 |
Why?
|
| Image Enhancement | 4 | 2014 | 2873 | 0.300 |
Why?
|
| Magnetic Resonance Spectroscopy | 6 | 2023 | 3744 | 0.300 |
Why?
|
| Fibrosis | 6 | 2018 | 2012 | 0.290 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2013 | 1245 | 0.290 |
Why?
|
| Propanolamines | 1 | 2007 | 161 | 0.290 |
Why?
|
| Systole | 5 | 2017 | 927 | 0.290 |
Why?
|
| Electrophysiology | 2 | 2009 | 1267 | 0.270 |
Why?
|
| Exercise Test | 12 | 2018 | 2082 | 0.270 |
Why?
|
| Ion Channels | 2 | 2009 | 1043 | 0.270 |
Why?
|
| Heart Septum | 1 | 2007 | 294 | 0.270 |
Why?
|
| Echocardiography, Three-Dimensional | 3 | 2024 | 606 | 0.270 |
Why?
|
| Cardiovascular Diseases | 5 | 2020 | 15314 | 0.270 |
Why?
|
| Carbazoles | 1 | 2007 | 220 | 0.260 |
Why?
|
| Heart Rate | 3 | 2021 | 4042 | 0.260 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 533 | 0.260 |
Why?
|
| Hypertrophy, Right Ventricular | 3 | 2018 | 107 | 0.260 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 1895 | 0.260 |
Why?
|
| Diseases in Twins | 1 | 2007 | 449 | 0.250 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 2 | 2018 | 535 | 0.250 |
Why?
|
| Muscular Dystrophies | 1 | 2007 | 386 | 0.250 |
Why?
|
| Biomedical Research | 1 | 2020 | 3328 | 0.250 |
Why?
|
| Treatment Outcome | 34 | 2024 | 63767 | 0.250 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2016 | 842 | 0.240 |
Why?
|
| Ion Channel Gating | 7 | 2012 | 434 | 0.240 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2011 | 467 | 0.240 |
Why?
|
| Health Care Costs | 1 | 2017 | 3194 | 0.230 |
Why?
|
| Follow-Up Studies | 27 | 2021 | 38800 | 0.230 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2019 | 2227 | 0.220 |
Why?
|
| Audiovisual Aids | 1 | 2024 | 100 | 0.220 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2015 | 192 | 0.210 |
Why?
|
| Tachycardia, Ventricular | 5 | 2018 | 1285 | 0.210 |
Why?
|
| Ventricular Function | 4 | 2020 | 408 | 0.210 |
Why?
|
| Quality Improvement | 2 | 2017 | 3741 | 0.210 |
Why?
|
| Pulsatile Flow | 2 | 2002 | 316 | 0.210 |
Why?
|
| Cardiology | 3 | 2020 | 1676 | 0.210 |
Why?
|
| Ganglia, Spinal | 6 | 2010 | 520 | 0.210 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2006 | 489 | 0.200 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2001 | 45 | 0.200 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 1219 | 0.200 |
Why?
|
| Heart Transplantation | 7 | 2021 | 3032 | 0.200 |
Why?
|
| Hemangioma | 2 | 2011 | 723 | 0.190 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 810 | 0.190 |
Why?
|
| Mitral Valve | 2 | 2024 | 1458 | 0.190 |
Why?
|
| Infant, Newborn | 23 | 2016 | 25765 | 0.190 |
Why?
|
| Heart Valve Prosthesis | 3 | 2020 | 1494 | 0.190 |
Why?
|
| Middle Aged | 37 | 2024 | 214698 | 0.190 |
Why?
|
| Respiratory Mechanics | 2 | 2016 | 683 | 0.190 |
Why?
|
| Prospective Studies | 19 | 2024 | 53268 | 0.190 |
Why?
|
| Drug Discovery | 1 | 2009 | 1055 | 0.180 |
Why?
|
| Vascular Fistula | 1 | 2000 | 48 | 0.180 |
Why?
|
| Oximetry | 1 | 2003 | 459 | 0.180 |
Why?
|
| Echocardiography, Doppler, Pulsed | 2 | 2011 | 69 | 0.170 |
Why?
|
| Abnormalities, Multiple | 3 | 2011 | 1415 | 0.170 |
Why?
|
| Sensitivity and Specificity | 8 | 2024 | 14543 | 0.170 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2020 | 272 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 7 | 2014 | 937 | 0.170 |
Why?
|
| Hemodynamics | 7 | 2018 | 4189 | 0.170 |
Why?
|
| Coronary Aneurysm | 1 | 2002 | 231 | 0.170 |
Why?
|
| Anemia | 1 | 2008 | 1483 | 0.160 |
Why?
|
| Cell Line | 9 | 2009 | 15645 | 0.160 |
Why?
|
| Cardiac Volume | 2 | 2010 | 200 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 1 | 2024 | 1678 | 0.160 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2014 | 576 | 0.160 |
Why?
|
| Stents | 5 | 2015 | 3282 | 0.160 |
Why?
|
| ROC Curve | 4 | 2018 | 3499 | 0.160 |
Why?
|
| Models, Cardiovascular | 2 | 2012 | 958 | 0.160 |
Why?
|
| Neurons, Afferent | 4 | 2005 | 495 | 0.150 |
Why?
|
| Fibroma | 3 | 2011 | 187 | 0.150 |
Why?
|
| Gadolinium | 4 | 2009 | 945 | 0.150 |
Why?
|
| Protein Subunits | 4 | 2012 | 947 | 0.150 |
Why?
|
| Bioprosthesis | 2 | 2020 | 596 | 0.150 |
Why?
|
| Diskectomy | 1 | 2018 | 204 | 0.140 |
Why?
|
| Boston | 10 | 2021 | 9213 | 0.140 |
Why?
|
| Regional Blood Flow | 4 | 2012 | 1501 | 0.140 |
Why?
|
| Risk Factors | 21 | 2024 | 72453 | 0.140 |
Why?
|
| Fetal Heart | 1 | 2018 | 281 | 0.140 |
Why?
|
| Behavior Therapy | 1 | 2022 | 858 | 0.140 |
Why?
|
| Databases, Factual | 6 | 2018 | 7816 | 0.130 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2016 | 62 | 0.130 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 613 | 0.130 |
Why?
|
| Liver | 3 | 2021 | 7382 | 0.130 |
Why?
|
| Oxygen Consumption | 6 | 2019 | 1825 | 0.130 |
Why?
|
| Protons | 1 | 2021 | 1116 | 0.130 |
Why?
|
| Pulmonary Veins | 3 | 2011 | 733 | 0.130 |
Why?
|
| Poisson Distribution | 1 | 2017 | 506 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2020 | 790 | 0.130 |
Why?
|
| Diffusion of Innovation | 1 | 2020 | 710 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2018 | 1725 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 2 | 2015 | 1442 | 0.130 |
Why?
|
| Marijuana Smoking | 1 | 2018 | 254 | 0.120 |
Why?
|
| Coronary Angiography | 4 | 2018 | 4512 | 0.120 |
Why?
|
| Cross-Sectional Studies | 11 | 2022 | 25194 | 0.120 |
Why?
|
| Radiation Protection | 1 | 2018 | 427 | 0.120 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2014 | 15 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 5 | 2010 | 4400 | 0.120 |
Why?
|
| Heart Failure | 5 | 2022 | 11100 | 0.120 |
Why?
|
| Radiography | 7 | 2013 | 6950 | 0.120 |
Why?
|
| Pichia | 1 | 2014 | 48 | 0.120 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2015 | 920 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2014 | 1351 | 0.110 |
Why?
|
| Hospitals, Pediatric | 4 | 2018 | 1816 | 0.110 |
Why?
|
| Heart Septal Defects | 1 | 2014 | 189 | 0.110 |
Why?
|
| Elasticity | 1 | 2015 | 653 | 0.110 |
Why?
|
| Aequorin | 1 | 2012 | 15 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 7281 | 0.110 |
Why?
|
| Arteries | 1 | 2018 | 1114 | 0.110 |
Why?
|
| Postoperative Complications | 6 | 2017 | 15365 | 0.100 |
Why?
|
| Electrocardiography | 9 | 2021 | 6319 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3057 | 0.100 |
Why?
|
| Bundle-Branch Block | 1 | 2014 | 269 | 0.100 |
Why?
|
| Feasibility Studies | 5 | 2020 | 5096 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3169 | 0.100 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1995 | 546 | 0.100 |
Why?
|
| Watchful Waiting | 1 | 2016 | 502 | 0.100 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2016 | 581 | 0.100 |
Why?
|
| Aged | 16 | 2022 | 164457 | 0.100 |
Why?
|
| beta-Thalassemia | 1 | 2014 | 226 | 0.100 |
Why?
|
| Connexin 43 | 1 | 2012 | 201 | 0.100 |
Why?
|
| Organ Size | 6 | 2015 | 2239 | 0.100 |
Why?
|
| Prognosis | 9 | 2015 | 29078 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 2 | 2014 | 926 | 0.100 |
Why?
|
| Membrane Potentials | 7 | 2014 | 1103 | 0.090 |
Why?
|
| Registries | 4 | 2018 | 8173 | 0.090 |
Why?
|
| Vena Cava, Inferior | 2 | 2011 | 450 | 0.090 |
Why?
|
| Fetal Diseases | 2 | 2007 | 910 | 0.090 |
Why?
|
| Nicotinic Antagonists | 1 | 2011 | 94 | 0.090 |
Why?
|
| Program Evaluation | 2 | 2017 | 2456 | 0.090 |
Why?
|
| Disease Progression | 5 | 2016 | 13319 | 0.090 |
Why?
|
| Blood Pressure | 5 | 2015 | 8405 | 0.090 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2014 | 353 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2022 | 6152 | 0.090 |
Why?
|
| Cicatrix | 1 | 2016 | 770 | 0.090 |
Why?
|
| Knee Injuries | 1 | 2015 | 484 | 0.090 |
Why?
|
| Linear Models | 5 | 2016 | 5833 | 0.090 |
Why?
|
| Sarcomeres | 1 | 2013 | 368 | 0.090 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2010 | 39 | 0.090 |
Why?
|
| Multivariate Analysis | 8 | 2018 | 12021 | 0.090 |
Why?
|
| Pandemics | 2 | 2020 | 8444 | 0.090 |
Why?
|
| Reference Values | 3 | 2022 | 4884 | 0.090 |
Why?
|
| Brachiocephalic Trunk | 1 | 2009 | 41 | 0.080 |
Why?
|
| Biological Assay | 1 | 2012 | 629 | 0.080 |
Why?
|
| Hospitalization | 2 | 2021 | 10342 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 1819 | 0.080 |
Why?
|
| Age Factors | 5 | 2024 | 18159 | 0.080 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2008 | 29 | 0.080 |
Why?
|
| Public Health | 1 | 2022 | 2623 | 0.080 |
Why?
|
| Ectopia Cordis | 1 | 2008 | 5 | 0.080 |
Why?
|
| Arthroscopy | 1 | 2015 | 948 | 0.080 |
Why?
|
| Equipment Design | 4 | 2018 | 3513 | 0.080 |
Why?
|
| Risk Assessment | 9 | 2024 | 23470 | 0.080 |
Why?
|
| Palliative Care | 3 | 2013 | 3549 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2012 | 721 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2010 | 1690 | 0.080 |
Why?
|
| Recombinant Proteins | 4 | 2014 | 6517 | 0.080 |
Why?
|
| Rhabdomyoma | 2 | 2011 | 53 | 0.080 |
Why?
|
| Area Under Curve | 3 | 2018 | 1617 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 495 | 0.070 |
Why?
|
| Electrophysiological Phenomena | 1 | 2009 | 309 | 0.070 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2008 | 151 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2014 | 6790 | 0.070 |
Why?
|
| Locomotion | 1 | 1989 | 379 | 0.070 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 551 | 0.070 |
Why?
|
| Patient Care Management | 1 | 2010 | 300 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 1989 | 275 | 0.070 |
Why?
|
| Heart Aneurysm | 1 | 2007 | 114 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2012 | 905 | 0.070 |
Why?
|
| Disease Management | 1 | 2017 | 2457 | 0.070 |
Why?
|
| Critical Pathways | 1 | 2010 | 473 | 0.070 |
Why?
|
| Survival Rate | 4 | 2018 | 12645 | 0.070 |
Why?
|
| Heart Atria | 3 | 2018 | 1321 | 0.070 |
Why?
|
| Vascular Resistance | 1 | 2009 | 936 | 0.070 |
Why?
|
| Canada | 3 | 2020 | 2090 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 1384 | 0.060 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2005 | 24 | 0.060 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2005 | 33 | 0.060 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2005 | 56 | 0.060 |
Why?
|
| Neuropeptides | 2 | 2001 | 944 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4197 | 0.060 |
Why?
|
| Teratoma | 2 | 2011 | 397 | 0.060 |
Why?
|
| Receptors, GABA-A | 1 | 2009 | 624 | 0.060 |
Why?
|
| United States | 9 | 2021 | 70474 | 0.060 |
Why?
|
| Heart Valve Diseases | 1 | 2012 | 1034 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2012 | 1529 | 0.060 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 15561 | 0.060 |
Why?
|
| Odds Ratio | 5 | 2016 | 9600 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2014 | 10750 | 0.060 |
Why?
|
| Prenatal Diagnosis | 2 | 2010 | 1256 | 0.060 |
Why?
|
| Hospital Costs | 1 | 2010 | 959 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6462 | 0.060 |
Why?
|
| Capsaicin | 1 | 2004 | 226 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 10098 | 0.060 |
Why?
|
| Software | 1 | 2017 | 4401 | 0.060 |
Why?
|
| Tetrodotoxin | 2 | 2002 | 246 | 0.060 |
Why?
|
| Monitoring, Physiologic | 2 | 2008 | 1755 | 0.050 |
Why?
|
| Thoracic Duct | 1 | 2023 | 64 | 0.050 |
Why?
|
| Logistic Models | 5 | 2018 | 13172 | 0.050 |
Why?
|
| Transducers | 2 | 2018 | 240 | 0.050 |
Why?
|
| Cohort Studies | 8 | 2022 | 40538 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 1983 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5843 | 0.050 |
Why?
|
| Hemangioma, Capillary | 1 | 2002 | 62 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2012 | 2189 | 0.050 |
Why?
|
| Postoperative Period | 3 | 2012 | 1812 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2020 | 2109 | 0.050 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 2030 | 0.050 |
Why?
|
| Neuralgia | 2 | 2005 | 574 | 0.050 |
Why?
|
| Dilatation, Pathologic | 2 | 2016 | 516 | 0.050 |
Why?
|
| Polyvinyls | 1 | 2002 | 153 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2014 | 21698 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 2007 | 1134 | 0.050 |
Why?
|
| Coronary Stenosis | 2 | 2008 | 814 | 0.050 |
Why?
|
| Metals | 1 | 2005 | 708 | 0.050 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2003 | 279 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 311 | 0.040 |
Why?
|
| Transfection | 5 | 2008 | 5789 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2010 | 1852 | 0.040 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 11661 | 0.040 |
Why?
|
| Rats | 7 | 2014 | 23700 | 0.040 |
Why?
|
| Calcium | 1 | 2012 | 5656 | 0.040 |
Why?
|
| Animals | 12 | 2020 | 166578 | 0.040 |
Why?
|
| HEK293 Cells | 3 | 2014 | 4183 | 0.040 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 968 | 0.040 |
Why?
|
| Equipment Failure | 2 | 2006 | 572 | 0.040 |
Why?
|
| Thorax | 1 | 2022 | 543 | 0.040 |
Why?
|
| Sheep | 2 | 2013 | 1435 | 0.040 |
Why?
|
| Medical Records | 1 | 2004 | 1392 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2002 | 969 | 0.040 |
Why?
|
| Aortography | 1 | 2000 | 410 | 0.040 |
Why?
|
| Troponin | 1 | 2021 | 513 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 1284 | 0.040 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 76 | 0.040 |
Why?
|
| Veins | 1 | 2002 | 762 | 0.040 |
Why?
|
| Anesthesia | 1 | 2008 | 1558 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2000 | 829 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2020 | 786 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 2014 | 13513 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 20143 | 0.040 |
Why?
|
| Length of Stay | 3 | 2021 | 6299 | 0.040 |
Why?
|
| Radiographic Image Enhancement | 1 | 2002 | 868 | 0.040 |
Why?
|
| Troponin T | 1 | 2022 | 751 | 0.040 |
Why?
|
| Ohio | 1 | 2017 | 326 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2342 | 0.030 |
Why?
|
| Electric Stimulation | 3 | 2008 | 1729 | 0.030 |
Why?
|
| Kentucky | 1 | 2016 | 81 | 0.030 |
Why?
|
| Ontario | 1 | 2017 | 392 | 0.030 |
Why?
|
| Creatinine | 1 | 2022 | 1850 | 0.030 |
Why?
|
| Probability | 1 | 2001 | 2470 | 0.030 |
Why?
|
| Europe | 2 | 2013 | 3355 | 0.030 |
Why?
|
| Research Design | 3 | 2024 | 6066 | 0.030 |
Why?
|
| American Heart Association | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Germany | 1 | 2018 | 858 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1232 | 0.030 |
Why?
|
| Stainless Steel | 1 | 2015 | 79 | 0.030 |
Why?
|
| Incidence | 5 | 2015 | 20821 | 0.030 |
Why?
|
| Scotland | 1 | 2015 | 150 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3497 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2011 | 8131 | 0.030 |
Why?
|
| Hypertension | 1 | 2015 | 8365 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2018 | 592 | 0.030 |
Why?
|
| Sweden | 1 | 2018 | 1368 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2015 | 317 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2001 | 1179 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 1204 | 0.030 |
Why?
|
| Aftercare | 1 | 2020 | 893 | 0.030 |
Why?
|
| Norwood Procedures | 1 | 2016 | 191 | 0.030 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 1403 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 2145 | 0.030 |
Why?
|
| Rupture | 1 | 2015 | 433 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2014 | 4188 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2003 | 6337 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2022 | 1602 | 0.030 |
Why?
|
| Survivors | 1 | 2004 | 2303 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 17700 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2002 | 6228 | 0.030 |
Why?
|
| Flow Injection Analysis | 1 | 2012 | 21 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2019 | 2616 | 0.030 |
Why?
|
| Cerebellum | 1 | 2000 | 1486 | 0.030 |
Why?
|
| Comorbidity | 1 | 2007 | 10376 | 0.030 |
Why?
|
| Infection Control | 1 | 2020 | 972 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 548 | 0.030 |
Why?
|
| Luminescent Agents | 1 | 2012 | 49 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2001 | 1420 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2000 | 1487 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2015 | 985 | 0.030 |
Why?
|
| Binding Sites | 2 | 2012 | 6031 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2012 | 5381 | 0.020 |
Why?
|
| Nocardia | 1 | 1991 | 11 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2015 | 772 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 260 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 1655 | 0.020 |
Why?
|
| Pregnancy | 3 | 2008 | 29298 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 3017 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2015 | 610 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2018 | 1810 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2014 | 453 | 0.020 |
Why?
|
| Disulfides | 1 | 2012 | 455 | 0.020 |
Why?
|
| Netherlands | 1 | 2015 | 2180 | 0.020 |
Why?
|
| Codon | 1 | 2012 | 602 | 0.020 |
Why?
|
| CHO Cells | 2 | 2004 | 1394 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 452 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 346 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 849 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2018 | 1950 | 0.020 |
Why?
|
| Echocardiography, Stress | 1 | 2010 | 134 | 0.020 |
Why?
|
| Flumazenil | 1 | 2009 | 84 | 0.020 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2009 | 59 | 0.020 |
Why?
|
| Cricetinae | 2 | 2004 | 2427 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3430 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 11870 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 57622 | 0.020 |
Why?
|
| Physical Examination | 1 | 2015 | 1233 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2022 | 5036 | 0.020 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2009 | 83 | 0.020 |
Why?
|
| Gestational Age | 1 | 2018 | 3520 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4118 | 0.020 |
Why?
|
| Preoperative Care | 2 | 2013 | 2223 | 0.020 |
Why?
|
| Receptors, Purinergic P2X2 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 719 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 2001 | 1063 | 0.020 | |